Searchable abstracts of presentations at key conferences in endocrinology

ea0056p33 | Adrenal cortex (to include Cushing's) | ECE2018

ACTH stimulation test for study of primary aldosteronism

Cunha Nelson , Gomes Leonor , Paiva Isabel , Oliveira Diana , Lages Adriana , Ventura Mara , Fadiga Lucia , Catarino Diana , Carrilho Francisco

Introduction: Primary aldosteronism (PA) is the principal cause of arterial hypertension potentially treatable. The diagnosis is dependent of tests to identify patients who will benefit most with surgical treatment. ACTH stimulation test (AST) has been described as a useful confirmatory test, potentially identifying bilateral disease in patients without adrenal tumors.Aim: Evaluate the AST in patients with hypertension and positive screening test for PA,...

ea0056p104 | Clinical case reports - Pituitary/Adrenal | ECE2018

A new gene – TMEM127 – in familial pheochromocytoma/paraganglioma syndromes

Ventura Mara , Paiva Isabel , Melo Miguel , Lages Adriana , Oliveira Diana , Martins Diana , Cunha Nelson , Fadiga Lucia , Catarino Diana , Carrilho Francisco

Introduction: Pheochromocytomas are catecholamine-producing tumors originated from the chromaffin cells of the adrenal medulla. Although usually sporadic, this tumors could be associated with germline mutations in about 40% of cases. TMEM127 has recently been identified as a novel gene conferring increased susceptibility to pheochromocytoma.Case report: A 42-year-old woman was referred to our Hospital to perform a right adrenalectomy for pheochromocytoma...

ea0056p322 | Clinical case reports - Thyroid/Others | ECE2018

Performance-enhancing drugs and adverse endocrine effects

Oliveira Diana , Lages Adriana , Paiva Isabel , Ventura Mara , Cunha Nelson , Fadiga Lucia , Catarino Diana , Paiva Sandra , Carrilho Francisco

Introduction: Performance-enhancing drug (PED) use is currently a common practice both inside and outside the sports competition scenario, and its adverse health effects remain underappreciated.Case report: We report the case of a 26-year-old man, bodybuilding practitioner, no relevant medical history, family history of autoimmune disorders. Referred to the emergency room with polydipsia, polyuria, blurred vision associated with a post-prandial capillary...

ea0056ep68 | Diabetes, Obesity and Metabolism | ECE2018

Diabetic ketoacidosis and dapagliflozin: a case report

Catarino Diana , Ribeiro Cristina , Oliveira Diana , Martins Diana , Lages Adriana , Ventura Mara , Cunha Nelson , Fadiga Lucia , Marques Bernardo , Carrilho Francisco

Introduction: Dapagliflozin is an oral antidiabetic drug, recently approved for type 2 diabetes and is a sodium-glucose cotransporter type 2 inhibitor (iSGLT2). Its mechanism of action is glycosuria induction, associated with lowering glycemia. The effects of SGLT2 inhibition are insulin-independent, and efficacy is not affected by declining β-cell function or insulin resistance. Additional benefits: weight loss, reduction in blood pressure, lower inciden...

ea0073aep392 | Endocrine-Related Cancer | ECE2021

Malignant pheochromocytomas and paragangliomas: clinical and pathological characteristics of a tertiary hospital’ cohort

Guiomar Joana Reis , Moreno Carolina , Lages Adriana , Lúcia Fadiga , Diana Alexandra Festas Silva , Paiva Isabel

IntroductionPheochromocytomas (PHEO) and paragangliomas (PGL) are neuroendocrine tumors arising from the chromaffin cells of the adrenal medulla and extra-adrenal autonomic paraganglia, respectively. They are rare and generally benign neuroendocrine tumors. However, malignancy (defined as the evidence of metastases in nonchromaffin sites distant from the primary tumor) occurs in 2 to 26%. Malignant PHEO and PGL are very challenging malignancies associate...

ea0049ep44 | Adrenal cortex (to include Cushing's) | ECE2017

Late-night salivary cortisol: cut-off definition and diagnostic value in Cushing’s syndrome

Lages Adriana , Frade Joao , Paiva Isabel , Oliveira Patricia , Oliveira Diana , Martins Diana , Ventura Mara , Cunha Nelson , Rebelo-Marques Alexandre , Antunes Susana , Leitao Fatima , Carrilho Francisco

Background: The diagnosis of Cushing’s syndrome (CS) remains a challenge in clinical endocrinology. Several screening tests have been proposed to establish hypercortisolism. Late-night salivary cortisol (LNSC) is used as screening tool, however, individualized cut-off levels for each population must be defined.Methods: Three group of subjects were studied: healthy volunteers, suspected CS and proven CS. All patients collected saliva at 23.00 h using...

ea0049ep45 | Adrenal cortex (to include Cushing's) | ECE2017

Adrenal involvement in MEN1 families

Ventura Mara , Melo Miguel , Gomes Leonor , Saraiva Joana , Barros Luisa , Rodrigues Dircea , Oliveira Diana , Martins Diana , Lages Adriana , Cunha Nelson , Carrilho Francisco

Introduction: MEN1 is a rare autosomal dominant syndrome typically characterized by neoplastic lesions of parathyroid glands, anterior pituitary gland and endocrine pancreas. Several other tumours are associated with this syndrome, including adrenal lesions, but their prevalence and clinical characteristics (endocrine secretion and aggressiveness) are largely unknown.Objective: To determine the prevalence, clinical characteristics and the possible genoty...

ea0049ep392 | Clinical case reports - Thyroid/Others | ECE2017

Continuous glucose monitoring in glycogen storage disease type Ia – a major improvement for patients

Martins Diana , Oliveira Diana , Baptista Carla , Paiva Sandra , Vicente Nuno , Cardoso Luis , Lages Adriana , Ventura Mara , Cunha Nelson , Moreira Sonia , Clemente Hugo , Esperto Helder , Carrilho Francisco

Introduction: Glycogen storage disease (GSD) type Ia (von Gierke’s disease) is an inherited metabolic disorder of glycogen metabolism, caused by defects in the glucose-6-phosphatase complex, with associated risk of severe hypoglycemia within 3–4 h after a meal.The aim of the present study was to evaluate the efficacy of continuous glucose monitoring (CGM) system in determining the magnitude of hypoglycemia in patients with GSD type Ia.<p cl...

ea0049ep394 | Clinical case reports - Thyroid/Others | ECE2017

Endocrine manifestations of Woodhouse-Sakati Syndrome – a Portuguese case

Oliveira Diana , Paiva Sandra , Louro Pedro , Macario M Carmo , Duraes Joao , Martins Diana , Ventura Mara , Lages Adriana , Cunha Nelson , Carrilho Francisco

Introduction: Woodhouse-Sakati Syndrome (WSS) is a very rare autossomic recessive disorder caused by mutations in DCAF17 gene that primarily affects the endocrine and the nervous systems. It is associated with hypogonadism, diabetes mellitus, hypothyroidism, sensorineural hearing loss, alopecia and extrapyramidal findings. Treatment is symptomatic and managed by multidisciplinary teams. Less than 80 cases are reported to date.Case repor...

ea0041gp60 | Clinical Case Reports | ECE2016

Endoscopic ultrasound-guided ethanol ablation therapy for pancreatic insulinoma: an unusual strategy

Lages Adriana de Sousa , Oliveira Patricia , Paiva Isabel , Portela Francisco , Guelho Daniela , Cardoso Luis , Vicente Nuno , Oliveira Diana , Martins Diana , Ventura Mara , Carrilho Francisco

Introduction: Insulinomas are the most frequent cause of endogenous hypoglycaemia. 90 to 95% of these are benign. Surgical enucleation or resection is the standard treatment. Medical therapy focuses mainly on the use of diazoxide with few alternatives in patients with high surgical risk.Case-report: Female patient, 89 years-old, non-diabetic, with previous history of acute myocardial infarction, stroke with motor sequelae, pacemaker carrier and severe ao...